Anson Luke W, Chau Kevin, Sanderson Nicholas, Hoosdally Sarah, Bradley Phelim, Iqbal Zamin, Phan Hang, Foster Dona, Oakley Sarah, Morgan Marcus, Peto Tim E A, Crook Derrick W, Pankhurst Louise J
Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Present address: Genomic Research Laboratory, Division of Infectious Diseases, University of Geneva Hospitals, Rue Gabrielle-Perret-Gentil, 4, CH-1211 Geneva 14, Switzerland.
J Med Microbiol. 2018 Mar;67(3):347-357. doi: 10.1099/jmm.0.000664. Epub 2018 Jan 10.
Speed of bloodstream infection diagnosis is vital to reduce morbidity and mortality. Whole genome sequencing (WGS) performed directly from liquid blood culture could provide single-assay species and antibiotic susceptibility prediction; however, high inhibitor and human cell/DNA concentrations limit pathogen recovery. We develop a method for the preparation of bacterial DNA for WGS-based diagnostics direct from liquid blood culture.
We evaluate three commercial DNA extraction kits: BiOstic Bacteraemia, Amplex Hyplex and MolYsis Plus. Differential centrifugation, filtration, selective lysis and solid-phase reversible immobilization bead clean-up are tested to improve human cells/DNA and inhibitor removal. Using WGS (Illumina/MinION), we assess human DNA removal, pathogen recovery, and predict species and antibiotic susceptibility inpositive blood cultures of 44 Gram-negative and 54 Staphylococcus species.Results/Key findings. BiOstic kit extractions yield the greatest mean DNA concentration, 94-301 ng µl, versus 0-2.5 ng µl using Amplex and MolYsis kits. However, we note higher levels of inhibition (260/280 ratio 0.9-2.1) and human DNA (0.0-4.4×10 copies) in BiOstic extracts. Differential centrifugation (2000 g, 1 min) prior to BiOstic extraction reduces human DNA by 63-89 % with selective lysis minimizing by a further 62 %. Post-extraction bead clean-up lowers inhibition. Overall, 67 % of sequenced samples (Illumina MiSeq) contain <10 % human DNA, with >93 % concordance between WGS-based species and susceptibility predictions and clinical diagnosis. If >60 % of sequencing reads are human (7/98 samples) susceptibility prediction becomes compromised. Novel MinION-based WGS (n=9) currently gives rapid species identification but not susceptibility prediction.
Our method for DNA preparation allows WGS-based diagnosis direct from blood culture bottles, providing species and antibiotic susceptibility prediction in a single assay.
血流感染诊断的速度对于降低发病率和死亡率至关重要。直接从液体血培养物中进行全基因组测序(WGS)可提供单检测物种和抗生素敏感性预测;然而,高抑制剂和人类细胞/DNA浓度限制了病原体的回收。我们开发了一种直接从液体血培养物中制备用于基于WGS诊断的细菌DNA的方法。
我们评估了三种商业DNA提取试剂盒:BiOstic菌血症试剂盒、Amplex Hyplex试剂盒和MolYsis Plus试剂盒。测试了差速离心、过滤、选择性裂解和固相可逆固定磁珠净化,以改善人类细胞/DNA和抑制剂的去除。使用WGS(Illumina/MinION),我们评估了人类DNA的去除、病原体的回收,并对44种革兰氏阴性菌和54种葡萄球菌的阳性血培养物中的物种和抗生素敏感性进行了预测。结果/主要发现。BiOstic试剂盒提取产生的平均DNA浓度最高,为94 - 301 ng/µl,而使用Amplex和MolYsis试剂盒时为0 - 2.5 ng/µl。然而,我们注意到BiOstic提取物中的抑制水平较高(260/280比率为0.9 - 2.1)和人类DNA含量较高(0.0 - 4.4×10 copies)。在BiOstic提取之前进行差速离心(2000 g,1分钟)可使人类DNA减少63 - 89%,选择性裂解可进一步减少62%。提取后磁珠净化降低了抑制作用。总体而言,67%的测序样本(Illumina MiSeq)含有的人类DNA <10%,基于WGS的物种和敏感性预测与临床诊断之间的一致性>93%。如果>60%的测序读数是人类的(7/98个样本),敏感性预测就会受到影响。基于新型MinION的WGS(n = 9)目前可实现快速物种鉴定,但无法进行敏感性预测。
我们的DNA制备方法允许直接从血培养瓶中进行基于WGS的诊断,在一次检测中提供物种和抗生素敏感性预测。